← All trials
NCT04992182
Phase 2Interventional
Includes controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in participants with the disease or condition under study and to determine the common short-term side effects and risks.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 8, 2021
- Primary completion
- Aug 31, 2021
- Completion date
- Jun 30, 2022
- First posted
- Aug 5, 2021
- Last posted
- Aug 5, 2021
- Enrollment
- 534
- Arms / groups
- 4 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Universidad del DesarrolloLead sponsor
- Government of ChileCollaborator
- University of ChileCollaborator
- Pontificia Universidad Catolica de ChileCollaborator
- Universidad del DesarrolloReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.